JPS4916435B1 - - Google Patents

Info

Publication number
JPS4916435B1
JPS4916435B1 JP3545969A JP3545969A JPS4916435B1 JP S4916435 B1 JPS4916435 B1 JP S4916435B1 JP 3545969 A JP3545969 A JP 3545969A JP 3545969 A JP3545969 A JP 3545969A JP S4916435 B1 JPS4916435 B1 JP S4916435B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP3545969A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPS4916435B1 publication Critical patent/JPS4916435B1/ja
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12Triazine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP3545969A 1968-05-08 1969-05-08 Pending JPS4916435B1 (ja)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS339968 1968-05-08

Publications (1)

Publication Number Publication Date
JPS4916435B1 true JPS4916435B1 (ja) 1974-04-22

Family

ID=5373920

Family Applications (1)

Application Number Title Priority Date Filing Date
JP3545969A Pending JPS4916435B1 (ja) 1968-05-08 1969-05-08

Country Status (12)

Country Link
JP (1) JPS4916435B1 (ja)
AT (1) AT306930B (ja)
BE (1) BE732268A (ja)
BR (1) BR6908600D0 (ja)
CA (1) CA921904A (ja)
CH (1) CH527207A (ja)
DE (1) DE1922702A1 (ja)
ES (1) ES366910A1 (ja)
FR (1) FR2008048A1 (ja)
GB (1) GB1227691A (ja)
IT (1) IT1037009B (ja)
NL (1) NL6906909A (ja)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2012888C3 (de) * 1970-03-14 1981-04-02 Schering Ag, 1000 Berlin Und 4619 Bergkamen Verfahren zur Herstellung von 5-Azapyrimidinnucleosiden
US6905669B2 (en) 2001-04-24 2005-06-14 Supergen, Inc. Compositions and methods for reestablishing gene transcription through inhibition of DNA methylation and histone deacetylase
US6982253B2 (en) 2002-06-05 2006-01-03 Supergen, Inc. Liquid formulation of decitabine and use of the same
US7038038B2 (en) 2003-03-17 2006-05-02 Pharmion Corporation Synthesis of 5-azacytidine
US6943249B2 (en) 2003-03-17 2005-09-13 Ash Stevens, Inc. Methods for isolating crystalline Form I of 5-azacytidine
US6887855B2 (en) * 2003-03-17 2005-05-03 Pharmion Corporation Forms of 5-azacytidine
US20060014949A1 (en) * 2004-07-13 2006-01-19 Supergen Inc. Compositions and formulations of decitabine polymorphs and methods of use thereof
US7250416B2 (en) 2005-03-11 2007-07-31 Supergen, Inc. Azacytosine analogs and derivatives
US7700567B2 (en) 2005-09-29 2010-04-20 Supergen, Inc. Oligonucleotide analogues incorporating 5-aza-cytosine therein
EP2073807A1 (en) 2006-10-12 2009-07-01 Astex Therapeutics Limited Pharmaceutical combinations
US8916552B2 (en) 2006-10-12 2014-12-23 Astex Therapeutics Limited Pharmaceutical combinations
MX363023B (es) 2008-05-15 2019-03-05 Celgene Corp Formulaciones orales de analogos de citidina y metodos para usar los mismos.
ES2487525T3 (es) 2008-08-08 2014-08-21 Scinopharm Taiwan Ltd. Procedimiento para preparar nucleósidos de 5-azacitosina y sus derivados
RU2013148580A (ru) 2011-03-31 2015-05-10 Селджин Интернешнл Сарл Синтез 5-азацитидина
MX359314B (es) 2011-08-30 2018-09-25 Astex Pharmaceuticals Inc Star Formulaciones derivadas de decitabina.
RU2723590C2 (ru) 2015-07-02 2020-06-16 Оцука Фармасьютикал Ко., Лтд. Лиофилизированные фармацевтические композиции
WO2017090264A1 (ja) 2015-11-27 2017-06-01 大原薬品工業株式会社 5-アザシチジン又は其の2'-デオキシ体の5'位ジベンジル燐酸エステル
JP6162349B1 (ja) 2016-04-21 2017-07-12 大原薬品工業株式会社 5−アザシチジン類の糖部シリルエーテル誘導体
US10227374B2 (en) 2016-04-21 2019-03-12 Ohara Pharmaceutical Co., Ltd. Silyl etherified derivatives of 5-azacytidines in carbohydrate moiety
WO2017183215A1 (ja) 2016-04-21 2017-10-26 大原薬品工業株式会社 5-アザシチジン類の糖部シリルエーテル誘導体
KR20200035438A (ko) 2017-08-03 2020-04-03 오쓰까 세이야꾸 가부시키가이샤 약물 화합물 및 이의 정제 방법

Also Published As

Publication number Publication date
CA921904A (en) 1973-02-27
GB1227691A (ja) 1971-04-07
CH527207A (de) 1972-08-31
FR2008048A1 (ja) 1970-01-16
ES366910A1 (es) 1971-03-16
AT306930B (de) 1973-04-25
IT1037009B (it) 1979-11-10
DE1922702A1 (de) 1969-11-20
BR6908600D0 (pt) 1973-02-22
BE732268A (ja) 1969-10-01
NL6906909A (ja) 1969-11-11

Similar Documents

Publication Publication Date Title
AU1946070A (ja)
JPS4916435B1 (ja)
AU6168869A (ja)
AU6171569A (ja)
AR203075Q (ja)
AU4744468A (ja)
BE709479A (ja)
BE709320A (ja)
BE726277A (ja)
BE726242A (ja)
BE725196A (ja)
BE726503A (ja)
AU479393A (ja)
BE724436A (ja)
BE723943A (ja)
BE723559A (ja)
BE722159A (ja)
BE719619A (ja)
BE717860A (ja)
BE710619A (ja)
BE710267A (ja)
BE709496A (ja)
BE709484A (ja)
BE726860A (ja)
BE709446A (ja)